A University of Michigan reportsays that fibromyalgia pain is from an imbalance between the levels of neurotransmitters in the brain. Although there are currently no FDA approved drugs to combat the condition’s symptoms it is likely that three or four drugs will be approved within three years that specifically address the issue.